Chesterfield, MO, United States of America

Brett Mathew Sloman


 

Average Co-Inventor Count = 1.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2017-2019

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations in Radiotherapy by Brett Mathew Sloman

Introduction

Brett Mathew Sloman is an accomplished inventor based in Chesterfield, MO (US). He has made significant contributions to the field of radiotherapy, particularly through his innovative patents. With a total of two patents to his name, Sloman's work focuses on enhancing the precision and effectiveness of medical treatments.

Latest Patents

Sloman's latest patents include advancements in dose rate modulated stereotactic radio surgery. This technology relates to methods and systems for radiotherapy. The patent outlines a process that involves receiving a medical image that includes images of a target and an organ at risk (OAR). It also details how to generate a dose application plan based on a target dose and constraints on the OAR dose. The plan includes determining the placement of an arc for radiation application, dividing the arc into segments, and calculating the dose rate for each segment. This innovative approach aims to ensure that the predicted OAR dose satisfies the established constraints.

Career Highlights

Throughout his career, Brett Mathew Sloman has worked with notable companies in the medical technology sector. He has been associated with Elekta, Inc. and Impac Medical Systems, Inc. These experiences have allowed him to apply his expertise in developing cutting-edge solutions for radiotherapy.

Collaborations

[This section has been skipped due to space constraints.]

Conclusion

Brett Mathew Sloman's contributions to radiotherapy through his innovative patents demonstrate his commitment to improving medical technology. His work continues to influence the field and enhance patient care.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…